Daily Trading Analysis 26.02.2021

Technical & Fundamental analysis

Trading Analysis of USD/CHF As the head of Swiss Central Bank T. Jordan said: Last year we had to intervene aggressively in the foreign exchange market to reduce the strong pressure on the franc exchange rate; It is important to absorb this pressure to prevent the franc from strengthening too much; The franc is a defensive asset and an indicator of the level of global uncertainty; Last year, the Swiss economy showed better-than-expected resilience; At the end of 2020, the country's GDP is likely to have contracted by about 3%; The outlook for the economy remains uncertain and the situation is fragile; Fiscal and monetary policy must remain expansionary. Our Analysis: Provided that the currency pair is traded below 0.9065, follow the recommendations below: Time frame: 30 min Recommendation: short position Entry point: 0.9049 Take Profit 1: 0.9025 Take Profit 2: 0.9010 Alternative scenario: In case of breakout of the level 0.9065, follow the recommendations below: Time frame: 30 min Recommendation: long position Entry point: 0.9065 Take Profit 1: 0.9080 Take Profit 2: 0.9095 Learn More Trading Analysis of Dow Jones 30 Index The U.S. stock market closed on Thursday with a sharp decline of the main indices amid rising U.S. government bond yields, which triggered the sell-offs on the stock market because of concerns about the potential tightening of borrowing terms. The Dow Jones Industrial Average fell 559.85 points (1.75 percent) to 3,402.01 points. Our Analysis: Provided that the index is traded above 30930.00, follow the recommendations below: Time frame: H4 Recommendation: long position Entry point: 31230.00 Take Profit 1: 31725.00 Take Profit 2: 32070.00 Alternative scenario: In case of breakdown of the level 30930.00, follow the recommendations below: Time frame: H4 Recommendation: short position Entry point: 30930.00 Take Profit 1: 30760.00 Take Profit 2: 30525.00 Learn More Fundamental Trading Analysis of Pfizer  In early February, Pfizer stock suffered a setback as a result of a disappointing fourth-quarter report, even though the company had called for $15 billion in sales for a coronavirus vaccine throughout the year. This followed disappointing news regarding Pfizer's arthritis drug Xeljanz. In a pivotal study, Xeljanz failed to stand up to a competing drug. But Pfizer shares won when the company said its Covid vaccine, developed in collaboration with BioNTech, could repel mutated forms of the virus. Our Analysis: While the price is below 34.70, follow the recommendations below: Time frame: D1 Recommendation: short position Entry point: 33.82 Take Profit 1: 32.20 Take Profit 2: 31.70 Alternative scenario: If the level 34.70 is broken-out, follow the recommendations below: Time frame: D1 Recommendation: long position Entry point: 34.70 Take Profit 1: 35.50 Take Profit 2: 36.00 Learn More ‌ ‌ ‌ Risk Warning: Forex and CFD trading carry a high degree of risk. As such they may not be suitable for all investors. Investors should ensure they fully understand the risks associated with CFD trading before deciding to trade. Investors may choose to seek independent advice and should not risk more than they are prepared to lose.

PaxForex | London, London, E16AN United Kingdom Unsubscribe edwardlorilla1986.paxforex@blogger.com Customer Contact Data Notice Sent by info@paxforex.org